GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Oxford Nanopore Technologies ONT.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

210.40p

+2.24%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in GBP, from our data supplier.

FY2025

Revenue

£223.9m

FY2016FY2025

Net income

−£145.2m

FY2016FY2025

Free cash flow

−£66.3m

FY2016FY2025

Shareholders' equity

£463.3m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue£223.9m£183.2m£169.7m£198.6m£133.7m£113.9m£52.1m£32.5m£13.8m£4.5m
Research and development£97.7m£98.9m£103.8m£64.8m£76.0m£48.6m£40.5m£37.1m£35.0m£38.1m
Operating income−£155.3m−£152.3m−£168.6m−£98.5m−£165.3m−£72.5m−£80.9m−£62.2m−£65.9m−£65.0m
Net income−£145.2m−£146.2m−£154.5m−£91.0m−£167.6m−£61.2m−£72.2m−£53.1m−£56.5m−£59.1m
Diluted earnings per share-0.15-0.16-0.19-0.11-0.20-0.08-0.09-0.07-0.10-0.11

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets£622.5m£742.0m£777.1m£823.9m£841.9m£281.2m£164.7m£175.2m£119.3m£158.9m
Cash and short-term investments£255.3m£338.4m£270.1m£476.2m£618.5m£80.9m£13.1m£93.3m£67.8m£124.1m
Total liabilities£159.2m£155.7m£133.2m£130.3m£137.9m£95.3m£55.2m£32.3m£25.7m£13.7m
Debt£41.5m£46.0m£41.7m£34.1m£24.8m£23.6m£19.1m£9.5m£9.5m—
Shareholders' equity£463.3m£586.3m£643.9m£693.6m£704.0m£185.9m£109.5m£142.9m£93.6m£144.2m
Shares outstanding961m934m826m824m822m795m795m795m541m539m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−£62.8m−£109.9m−£137.3m−£49.4m−£53.8m−£63.8m−£48.7m−£55.5m−£66.3m−£51.2m
Capital spending−£3.5m−£13.9m−£27.3m−£42.2m−£30.8m−£26.5m−£30.3m−£17.8m−£19.7m−£3.0m
Free cash flow−£66.3m−£123.8m−£164.6m−£91.6m−£84.6m−£90.3m−£79.0m−£73.3m−£86.1m−£54.2m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Mar 2024Dec 2023Sept 2023
Revenue£116.7m£171.1m£52.8m£99.1m£84.1m£42.0m£83.7m£41.8m
Operating income−£50.7m−£116.4m−£38.9m−£75.3m−£77.0m−£38.5m−£93.8m−£46.9m
Net income−£48.0m−£109.3m−£35.9m−£71.5m−£74.7m−£37.3m−£84.4m−£42.2m
Diluted earnings per share-0.05-0.11-0.04-0.08-0.08-0.04-0.10-0.05
Cash from operations−£39.0m−£18.0m−£44.0m−£45.0m−£54.0m−£29.0m−£78.0m−£42.0m
Capital spending−£2.0m−£1.0m−£1.0m−£9.0m−£4.0m−£2.0m−£4.0m−£4.0m
Free cash flow−£41.0m−£19.0m−£45.0m−£54.0m−£58.0m−£31.0m−£82.0m−£46.0m
Total assets£565.4m£622.5m£671.7m£742.0m£722.7m£722.7m£787.4m£777.1m
Cash and short-term investments£184.8m£255.3m£331.8m£338.4m£259.0m£259.0m£270.1m£270.1m
Debt£5.7m£5.2m£5.8m£10.7m£5.1m£5.1m£4.3m£4.3m
Shareholders' equity£424.1m£463.3m£523.4m£586.3m£578.6m£578.6m£643.9m£643.9m

Financial ratios

Data as of 4 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-58.6%-83.1%-86.8%-41.1%-123.5%-63.6%
Net margin-64.9%-79.8%-91.1%-45.8%-125.4%-53.8%
Return on equity-31.3%-24.9%-24.0%-13.1%-23.8%-32.9%
Return on assets-23.3%-19.7%-19.9%-11.0%-19.9%-21.8%
Free cash flow yield-0.0%-0.0%-0.1%-0.0%-0.0%-0.0%
Revenue growth22.2%8.0%-14.6%48.6%17.4%118.7%
Earnings growth-0.7%-5.4%69.7%-45.7%173.7%-15.2%
Current ratio3.56x4.66x5.01x6.97x7.15x2.81x
Debt to equity0.01x0.01x0.01x-0.01x0.02x0.06x
Equity ratio74.4%79.0%82.9%84.2%83.6%66.1%
Interest coverage-46.86x-42.72x-66.79x-50.09x-181.75x-96.93x
R&D as a share of sales43.6%54.0%61.2%32.6%56.8%42.6%
Buybacks as a share of market value-3.2%-13.1%-0.2%-0.3%-3.4%0.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue4.1%14.5%76.9%
Operating income16.4%16.5%13.4%
Net income16.8%18.8%14.2%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-75.6%-74.1%-79.4%-100.4%
Net margin-71.6%-69.2%-74.9%-92.8%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings-8.5-8.2-11.1-22.3-34.2
Price to sales5.56.610.110.242.9

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.